Glycans—complex carbohydrates decorating the surfaces of cells and pathogens—are increasingly recognized as critical regulators of disease biology. As scientific understanding...

Anti-glycan antibodies represent one of the most promising yet challenging frontiers in biotechnology. Their ability to decode the "sugar language"...

In neuroscience, there's a quiet truth that shapes almost every experiment: the model you choose determines the questions you can...

Traditional neuroscience models often struggle to replicate human brain complexity, limiting predictive accuracy and creating challenges for drug discovery and...

The potential of induced pluripotent stem cells (iPSCs) to revolutionize regenerative medicine and phenotypic drug screening is undeniable. By providing...

Over the past decade, induced pluripotent stem cells (iPSCs) have reshaped the landscape of biological research. What began as a...

MEA electrophysiology and core neuroscience assays address key industry pain points—functional readouts, human relevance, and multimodal integration—supporting more predictive and...

The translational gap in CNS drug discovery drives high clinical failure rates. Transitioning from traditional 2D assays to human iPSC-derived...

The cell therapy industry is moving toward more precise, scalable, and controllable immunotherapies. As researchers address challenges in CIK cell...

SummaryThe clinical efficacy of solid tumor CAR-T therapies hinges on overcoming metabolic barriers within the tumor microenvironment. This article explores...